HMS Holdings Corp (HMSY) News

HMS Holdings Corp (HMSY)

Today's Latest Price: $31.98 USD

0.40 (-1.24%)

Updated Jun 3 2:33pm

Add HMSY to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 66 in Medical - Services

See all "A" rated Strong Buy stocks

Filter HMSY News Items

HMSY News Results

Event/TimeSymbolCompanyNews DetailStartEndChangePOWR Rating
Loading, please wait...

Latest HMSY News From Around the Web

Below are the latest news stories about Hms Holdings Corp that investors may wish to consider to help them evaluate HMSY as an investment opportunity.

Edited Transcript of HMSY earnings conference call or presentation 8-May-20 12:30pm GMT

Q1 2020 HMS Holdings Corp Earnings Call

Yahoo | May 29, 2020

Varian (VAR) Unveils New Features for Noona Software

This development, which is in response to the challenges brought on by the pandemic, is expected to boost Varian's (VAR) Oncology segment.

Yahoo | May 27, 2020

Baxter Receives CE Marking for Evo IQ Syringe Infusion System

Baxter (BAX) receives the CE marking and regulatory approval for the Evo IQ Syringe Infusion system that will help in optimizing efficiency for clinicians.

Yahoo | May 27, 2020

Here's Why You Should Add Surmodics to Your Portfolio Now

Investor confidence is high in Surmodics (SRDX) stock, thanks to solid prospects.

Yahoo | May 26, 2020

Does HMS Holdings Corp.'s (NASDAQ:HMSY) Past Performance Indicate A Stronger Future?

After looking at HMS Holdings Corp.'s (NasdaqGS:HMSY) latest earnings announcement (31 March 2020), I found it useful...

Yahoo | May 23, 2020

OPKO's BioReference Laboratories' Deal Brings Antibody Testing

OPKO Health's (OPK) subsidiary, BioReference Laboratories collaborates with MagnaCare to offer antibody testing to Labor groups in New York metropolitan area.

Yahoo | May 19, 2020

HMSY or TRHC: Which Is the Better Value Stock Right Now?

HMSY vs. TRHC: Which Stock Is the Better Value Option?

Yahoo | May 18, 2020

Here's Why You Should Retain Avanos Medical Stock for Now

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, stiff competition remains a concern.

Yahoo | May 18, 2020

Nevro's (NVRO) Senza Omnia SCS System Gets CE Mark Approval

Nevro (NVRO) received CE mark approval for the Senza Omnia SCS system, which is likely to boost its international presence.

Yahoo | May 18, 2020

ResMed Grows on Solid Ventilator Sales Amid Coronavirus Woes

ResMed (RMD) global sales increase on ramped-up demand for its critical care support products.

Yahoo | May 15, 2020

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7048 seconds.